A method for preparing high-EPA-yielding Schizochytrium and its application

Through normal pressure room temperature plasma mutagenesis technology and 2-deoxyglucose screening technology, high-yield eicosapentaenoic acid (EPA) strains were selected, which solved the problem of insufficient EPA yield in the existing technology and achieved the Significant improvement in EPA output and economic benefits.

CN115011490BActive Publication Date: 2024-12-03NANJING NORMAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210678501.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-06-15
Publication Date
2024-12-03
Estimated Expiration
2042-06-15

AI Technical Summary

Technical Problem

The existing technology is difficult to effectively increase the production of eicosapentaenoic acid (EPA). Deep-sea fish oil has high production costs and insufficient output, which cannot meet market demand. Traditional fermentation optimization strategies are difficult to further increase EPA production, and new strains of high-yield microbials need to be developed. .

Method used

The high-yield EPA-rich schichytriacetium strains were selected and bred by normal pressure room temperature plasma (ARTP) mutagenesis technology, 2-deoxyglucose (2-DG) plate screening technology, shake flask fermentation and GC quantitative analysis technology, and the ARTP mutagenesis was treated. Dilute and evenly coat on solid plates, select single colonies for shake flask fermentation and EPA yield detection, and screen high-yield EPA strains.

Benefits of technology

Two high-yield mutant strains were successfully obtained, and EPA output increased by 23.32% and 41.27% respectively, with significant economic effects and stable traits, meeting the market demand for EPA.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115011490B_ABST
    Figure CN115011490B_ABST
Patent Text Reader

Abstract

The invention provides a method for preparing a high-yield EPA schizochytrium. The method comprises the following steps: using atmospheric pressure room temperature plasma (ARTP) mutagenesis technology to carry out mutation breeding, using 2-deoxyglucose (2-DG) plate screening technology, and using shake flask fermentation and GC quantitative analysis technology to select and breed high-yield EPA strains, and finally obtaining two high-yield mutant strains, wherein the EPA yield of one schizochytrium strain is increased by 23.32%, and the EPA yield of the other schizochytrium strain is increased by 41.27%, and the economic effect is remarkable.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of microbial genetic breeding, and relates to a method for producing a schizochytrium mutant strain of eicosapentaenoic acid, namely a method for preparing a schizochytrium with high EPA production and an application thereof. Background Art

[0002] Eicosapentaenoic acid (EPA) is a ω-3 polyunsaturated fatty acid, which is an important fatty acid that cannot be synthesized by the human body but is indispensable. Increasing the intake and absorption of EPA on the basis of daily diet has obvious effects on the prevention and treatment of arteriosclerosis, cerebral thrombosis and hypertension. The development and utilization of EPA has become one of the hot topics in the field of health products and medicine. At present, the main commercial source of EPA is deep-sea fish oil, but the production cost of deep-sea fish oil is high, and the output cannot meet the market demand. With the expansion of EPA's application and the increase in demand, it is very important to develop new sources of EPA raw materials.

[0003] Schizochytrium is a fungus-like unicellular heterotrophic protist with advantages such as fast growth rate and high intracellular EPA and fatty acid content, and can be used as an alternative source for EPA production.

[0004] 2-Deoxyglucose (2-DG) is a glucose analog that inhibits the growth of yeast and filamentous fungi and, when incorporated into an appropriate culture medium, does not cause catabolite repression in mutant strains, only allowing mutant strains resistant to this form of repression to form colonies.

[0005] It is difficult to further increase the yield of EPA using traditional fermentation optimization strategies, so it is particularly important to cultivate new strains of EPA-producing microorganisms. The new atmospheric pressure room temperature plasma (ARTP) mutagenesis instrument has many advantages, such as fast mutation, high mutation diversity, and simplicity. Summary of the invention

[0006] In view of the shortcomings of the prior art, the present invention utilizes atmospheric pressure room temperature plasma (ARTP) mutagenesis technology, 2-deoxyglucose (2-DG) plate screening technology, shake flask fermentation and GC quantitative analysis technology to select and breed EPA high-yield strains, and provides a method for preparing high-yield EPA schizochytrium.

[0007] Specifically, the present invention provides a method for preparing high-yield EPA Schizochytrium, comprising the following steps:

[0008] S1: Select Schizochytrium in the logarithmic period and prepare a bacterial suspension with sterile distilled water;

[0009] S2: placing the bacterial suspension in an ARTP mutagenizer for irradiation treatment;

[0010] S3: dilute the irradiated bacterial suspension and spread it evenly on a solid plate, and store it in an incubator away from light;

[0011] S4: Select a single colony for shake flask fermentation, and select the bacterial liquid with a high lethality rate after irradiation as the starting strain;

[0012] S5: Detect EPA production through plate screening and shake flask fermentation;

[0013] S6: Screening of Schizochytrium strains with high EPA production based on EPA production.

[0014] The bacterial suspension of the present invention is prepared by using sterile distilled water in the logarithmic period of Schizochytrium, and the cell concentration OD660 value of the bacterial suspension is 0.6-0.8.

[0015] The method of irradiating the bacterial suspension using the ARTP mutagenizer in the present invention comprises the following steps:

[0016] S21: Take the bacterial suspension and spread it on a sterile slide, transfer the sterile slide to the groove of the ARTP mutagenizer, and place an EP tube under the groove;

[0017] S22: Turn on the ARTP mutagenizer, set the radiation time to 15-20s, the power to 110w, and the gas volume to 10SLM;

[0018] S23: After the mutagenesis is completed, the slide is transferred to an EP tube containing 1 mL of 1 mol / L sorbitol and eluted by shaking to form a new bacterial suspension.

[0019] The light-proof storage temperature of the present invention is 26-30° C., and the culture time is 3 days.

[0020] The culture medium used in the solid plate of the present invention is a 2-DG solid culture medium. The components of the 2-DG solid culture medium are calculated by weight. Per 1000 parts of the solid culture medium, the components include 12 parts of sodium sulfate, 2 parts of magnesium sulfate heptahydrate, 4 parts of ammonium sulfate, 0.5 parts of potassium chloride, 0.65 parts of potassium sulfate, 0.17 parts of calcium chloride, 10 parts of monosodium glutamate, 50 parts of glucose, 1 part of potassium dihydrogen phosphate, 10 parts of yeast powder, 0.6 parts of 2-DG, 20 parts of agar powder, and the balance is sterile water.

[0021] The components of the fermentation medium selected for the fermentation culture in the present invention are measured by mass. Per 1000 parts of the fermentation medium, the fermentation medium includes 12 parts of sodium sulfate, 2 parts of magnesium sulfate heptahydrate, 4 parts of ammonium sulfate, 0.5 parts of potassium chloride, 0.65 parts of potassium sulfate, 0.17 parts of calcium chloride, 10 parts of monosodium glutamate, 0.6 parts of malic acid, 50 parts of glucose, 1 part of potassium dihydrogen phosphate, 10 parts of yeast powder, 5 parts of corn steep liquor powder, and the balance is sterile water.

[0022] The method for preparing high-EPA-yielding Schizochytrium of the present invention is used in producing high-EPA-yielding Schizochytrium.

[0023] Compared with the prior art, the present invention has the following beneficial effects:

[0024] The invention provides a method for preparing a high-yield EPA schizochytrium. The method comprises the following steps: using atmospheric pressure room temperature plasma (ARTP) mutagenesis technology to carry out mutation breeding, using 2-deoxyglucose (2-DG) plate screening technology, shaking flask fermentation and GC quantitative analysis technology to select and breed EPA high-yield strains, and finally obtaining two high-yield mutant strains. The EPA yield of one schizochytrium strain is increased by 23.32%, and that of the other schizochytrium strain is increased by 41.27%, and the economic effect is remarkable.

[0025] The results showed that at a power of 110W and a gas volume of 10SLM, mutant 1 was obtained after ARTP mutagenesis for 20s. After 120h of shake flask fermentation, the biomass, total oil content, and EPA production of mutant 1 increased by 17.88%, 39.28%, and 23.32% respectively compared with the original strain, and the EPA production was 7.12g / L. After ARTP mutagenesis for 20s, 0.6g / L 2-DG solid medium was used as the screening plate to obtain mutant 2. The biomass, total oil content, and EPA production of mutant 2 increased by 34.14%, 58.92%, and 41.27% respectively compared with the original strain, and the EPA production was 7.75g / L. The two strains of Schizochytrium were subcultured and the characters were stable. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 The mortality rate of wild-type Schizochytrium sp. HX-308 under different treatment time in ARTP mutagen instrument.

[0027] Figure 2 The mortality rate of mutagenic Schizochytrium sp. HX-308 when adding different concentrations of 2-DG.

[0028] Figure 3 EPA production of wild-type Schizochytrium sp. HX-308 and mutant 1.

[0029] Figure 4 EPA production of wild-type Schizochytrium sp. HX-308 and mutant 2.

[0030] Figure 5 Biomass and fatty acid content of wild-type Schizochytrium sp. HX-308 and mutant 1 and mutant 2. DETAILED DESCRIPTION

[0031] In order to better reflect the technical effects of the present invention, the embodiments of the present invention are further described below. The examples are only used to explain the present invention and are not used to limit the scope of the present invention.

[0032] Example 1

[0033] The steps for obtaining Schizochytrium sp. HX-308 high-EPA production strain and mutation lethality are as follows:

[0034] (1) Seed solution preparation: In a sterile clean bench, use an inoculation loop to pick a single colony from a fresh solid culture medium, inoculate it into a conical flask containing 50 mL of seed culture medium, and culture it in a shaker at 28°C and 170 rpm for 24 h. Take 1 ml of the bacterial solution and add it to a new seed culture medium for another 24 to 36 h.

[0035] (2) Preparation of bacterial suspension: Take an appropriate amount of bacterial suspension and dilute it to adjust the cell OD600 value to between 0.6 and 0.8 for ARTP mutagenesis treatment;

[0036] (3) ARTP mutagenesis: Take 10uL of the above bacterial suspension and evenly spread it on a sterile slide, place the slide in a culture dish and transfer it to the groove of the ARTP mutagenizer. The corresponding EP tube is fixed on the fixed seat below the groove to receive the slide. The EP tube contains 1mL of sterile distilled water. The radiation time of the ARTP mutagenizer is 0s, 10s, 20s, 30s, 40s, 50s, and 60s. The power is set to 110W and the gas volume is set to 10SLM. After the mutagenesis is completed, take out the EP tube containing the slide, shake for 1min, so that the bacteria on the slide are completely resuspended in the EP tube, take 80uL of the resuspension and spread it on the solid plate, and place it in a 28°C incubator for 2 to 3d. The number of single colonies grown was counted, and the lethality at different treatment times of the ARTP mutagen was calculated. The treatment time of 20s with a lethality of about 90% was selected as the basis for subsequent mutagenesis treatment. Single colonies with large morphology and high yield were selected and inoculated into the seed culture medium. The colonies were subcultured to a new seed culture medium every 24 hours for three consecutive subcultures. Then 10 ml was taken to the fermentation medium for continuous culture for 4 days. The EPA content of the strain was measured at 48h, 72h, 96h, and 120h, and the biomass and fatty acid content were measured at the end of fermentation at 120h.

[0037] The preparation method of the seed culture medium is as follows: take 12g of sodium sulfate, 2g of magnesium sulfate heptahydrate, 4g of ammonium sulfate, 0.5g of potassium chloride, 0.65g of potassium sulfate, 0.17g of calcium chloride, 10g of monosodium glutamate, 50g of glucose, 1g of potassium dihydrogen phosphate, 10g of yeast powder, add the remaining amount of sterile water to a volume of 1L, the pH is natural, and sterilize for 30min under the conditions of 1×105Pa and 115°C.

[0038] The preparation method of the fermentation medium for fermentation culture is as follows: 12g of sodium sulfate, 2g of magnesium sulfate heptahydrate, 4g of ammonium sulfate, 0.5g of potassium chloride, 0.65g of potassium sulfate, 0.17g of calcium chloride, 10g of monosodium glutamate, 0.6g of malic acid, 50g of glucose, 1g of potassium dihydrogen phosphate, 10g of yeast powder, 5g of corn steep liquor powder, the balance of sterile water is added to a volume of 1L, the pH is natural, and sterilization is carried out at 1×105Pa and 115°C for 30min.

[0039] The preparation method of the solid culture medium is as follows: 12g of sodium sulfate, 2g of magnesium sulfate heptahydrate, 4g of ammonium sulfate, 0.5g of potassium chloride, 0.65g of potassium sulfate, 0.17g of calcium chloride, 10g of monosodium glutamate, 50g of glucose, 1g of potassium dihydrogen phosphate, 10g of yeast powder, 20g of agar powder, the balance of which is supplemented with sterile water to a volume of 1L, the pH is natural, and sterilization is performed at 1×105Pa and 115°C for 30min.

[0040] The solid plate uses 2-DG solid culture medium, and the preparation method of the 2-DG solid culture medium is as follows: take 12g of sodium sulfate, 2g of magnesium sulfate heptahydrate, 4g of ammonium sulfate, 0.5g of potassium chloride, 0.65g of potassium sulfate, 0.17g of calcium chloride, 10g of monosodium glutamate, 50g of glucose, 1g of potassium dihydrogen phosphate, 10g of yeast powder, 0.6g of 2-DG, 20g of agar powder, add the remaining amount of sterile water to a volume of 1L, the pH is natural, and sterilize for 30min under the conditions of 1×105Pa and 115°C.

[0041] EPA content detection: shake flask fermentation culture to measure EPA content. Specifically, take 1-2 ml shake flask fermentation liquid into a 2 ml centrifuge tube, centrifuge at 12000rpm for 2 minutes, discard the supernatant, add 500ul, 0.5mol / L sodium hydroxide methanol solution, mix well. Then put the centrifuge tube on an oscillator, oscillate at 12000rpm for 2 hours, add 40ul concentrated sulfuric acid, 800ul n-hexane and oscillate for another 10 minutes, and finally centrifuge at 12000rpm for 3 minutes, take the upper organic phase into the intubation tube in the liquid phase vial, and measure the EPA content in the upper gas phase.

[0042] Detection of strain biomass: After culturing the fermentation broth for 120 h, take 2 mL of the bacterial solution and put it into an EP tube, dry it and weigh it to determine the biomass.

[0043] Detection of fatty acid content: Use a measuring cylinder to measure 50mL of fermentation liquid and pour it into the bottle, adjust the pH to between 10-12 with NaOH, then add 0.3% of cell wall breaking enzyme, shake the bottle at 50℃, 170rpm for 24h, and check whether the cell wall of the strain is successfully broken. After success, add 50mL of anhydrous ethanol at a ratio of 1:1 and mix well to precipitate protein, then add 50mL of n-hexane at a ratio of 1:1, shake well and centrifuge. After stratification, absorb the upper n-hexane and evaporate it in a 40℃ water bath to collect the oil. After completion, bake it in an oven for ten minutes to volatilize the remaining n-hexane, and finally weigh the fatty acid weight.

[0044] The lethality curve of the ARTP mutagenizer is as follows: Figure 1 As shown, EPA high-yielding strains were selected through ARTP mutagen irradiation, shake flask fermentation and GC quantitative analysis. Figure 3 and Figure 5 As shown, a high-yield mutant strain was obtained after the EPA yield was increased. Its biomass, total oil content and EPA yield were increased by 17.88%, 39.28% and 23.32% respectively compared with the original strain, and the EPA yield was 7.12g / L.

[0045] Example 2

[0046] Obtaining a high-EPA-producing strain of Schizochytrium sp. HX-308 specifically comprises the following steps:

[0047] (1) Seed solution preparation: In a sterile clean bench, use an inoculation loop to pick a single colony from a fresh solid culture medium, inoculate it into a conical flask containing 50 mL of seed culture medium, and culture it in a shaker at 28°C and 170 rpm for 24 h. Take 1 ml of the bacterial solution and add it to a new seed culture medium for another 24 to 36 h.

[0048] (2) Preparation of bacterial suspension: Take an appropriate amount of bacterial suspension and dilute it to adjust the cell OD600 value to between 0.6 and 0.8 for ARTP mutagenesis treatment;

[0049] (3) ARTP mutagenesis: Take 10uL of the above bacterial suspension and evenly spread it on a sterile slide, place the slide in a culture dish and transfer it to the groove of the ARTP mutagenizer. The corresponding EP tube is fixed on the fixed seat below the groove to receive the slide. The EP tube contains 1mL of sterile distilled water. The radiation time of the ARTP mutagenizer is 0s, 10s, 20s, 30s, 40s, 50s, and 60s. The power is set to 110W and the gas volume is set to 10SLM. After the mutagenesis is completed, take out the EP tube containing the slide, shake for 1min, so that the bacteria on the slide are completely resuspended in the EP tube, take 80uL of the resuspension and spread it on the solid plate, and place it in a 28°C incubator for 2 to 3d. The number of single colonies grown was counted, and the lethality at different treatment times of the ARTP mutagenizer was calculated. The treatment time of 20s with a lethality of about 90% was selected as the basis for subsequent mutagenesis treatment. The bacterial solution after mutagenesis treatment was transferred to an EP tube containing 1 mL of normal saline, and oscillated to form a new bacterial suspension, which was diluted a certain number of times. 100 μL of the bacterial solution was spread on a screening plate with a certain mass concentration of 2-DG and cultured at 25°C for 3 days.

[0050] (4) Determine the concentration of 2-DG screening plates: Take the bacterial solution that has been induced for 20 seconds and spread it on 2-DG plates with concentrations of 0 g / L, 0.2 g / L, 0.4 g / L, 0.6 g / L, 0.8 g / L, and 1.0 g / L to make three parallel screening plates (see Table 1). After incubation at 28°C for 3 days, count the colonies on the plates and calculate the lethality (e.g. Figure 2 As shown). The strains on the screening plate with a lethality of about 90% were selected for subsequent culture and fermentation.

[0051] (5) Fermentation culture: From the strains on the screening plate with a lethality rate of about 90%, single colonies with large morphology and high yield were selected and inoculated into seed culture medium. The culture was subcultured to new seed culture medium every 24 hours for three consecutive subcultures. Then 10 ml was taken to fermentation medium for continuous culture for 4 days. The EPA content of the strains was measured at 48 hours, 72 hours, 96 hours, and 120 hours, respectively. The biomass and fatty acid content were measured at the end of fermentation at 120 hours.

[0052] Among them, the seed culture medium, fermentation medium, solid culture medium and 2-DG solid culture medium are the same as those in Example 1, and the EPA content determination, strain biomass determination and fatty acid content are the same as those in Example 1.

[0053] Table 1 The colony counts of the mutagenic Schizochytrium under the addition of different concentrations of 2-DG.

[0054]

[0055]

[0056] The lethality of the mutant strains induced by adding different concentrations of 2-DG is as follows Figure 2 As shown, the EPA high-yielding strain was selected through ARTP mutagen irradiation, 2-DG plate screening, shake flask fermentation and GC quantitative analysis. Figure 4 and Figure 5 As shown, a high-yield mutant strain was obtained after the EPA yield was measured. The EPA yield was increased by 41.27% compared with the wild-type Schizochytrium, the biomass was increased by 34.14%, and the fatty acid content was increased by 58.92%.

[0057] The above description is only the best embodiment of the present invention and is not intended to limit the protection scope of the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for preparing high-yield EPA Schizochytrium, characterized in that: The following steps are involved: S1: Select Schizochytrium in the logarithmic period and prepare a bacterial suspension with sterile distilled water; S2: placing the bacterial suspension in an ARTP mutagenizer for irradiation treatment; S3: dilute the irradiated bacterial suspension and spread it evenly on a solid plate, and store it in an incubator away from light; S4: Select a single colony for shake flask fermentation and select the bacterial liquid with high lethality after irradiation as the starting strain; S5: Through 2-DG plate screening, the strain on the screening plate with a lethality rate of 90% is selected for subsequent fermentation culture to detect EPA production; S6: Screening of Schizochytrium strains with high EPA production based on EPA production.

2. The method for preparing high-EPA-producing Schizochytrium according to claim 1, characterized in that: The bacterial suspension is prepared using sterile distilled water during the logarithmic period of Schizochytrium, and the cell concentration OD of the bacterial suspension is 600 The value is 0.6~0.

8.

3. The method for preparing high-EPA-producing Schizochytrium according to claim 1, characterized in that: The irradiation treatment of bacterial suspension using ARTP mutagenizer includes the following steps: S21: Take the bacterial suspension and spread it on a sterile slide, transfer the sterile slide to the groove of the ARTP mutagenizer, and place an EP tube under the groove; S22: Turn on the ARTP mutagenizer, set the radiation time to 20s, the power to 110w, and the gas volume to 10SLM; S23: After the mutagenesis is completed, the slide is transferred to an EP tube containing 1 mL of 1 mol / L sorbitol and eluted by shaking to form a new bacterial suspension.

4. The method for preparing high-EPA-producing Schizochytrium according to claim 1, characterized in that: The light-proof storage temperature is 26-30° C., and the culture time is 3 days.

5. The method for preparing high-EPA-producing Schizochytrium according to claim 1, characterized in that: The components of the fermentation medium selected for the fermentation culture are measured in parts by mass, and every 1000 parts of the fermentation medium includes: 12 parts of sodium sulfate, 2 parts of magnesium sulfate heptahydrate, 4 parts of ammonium sulfate, 0.5 parts of potassium chloride, 0.65 parts of potassium sulfate, 0.17 parts of calcium chloride, 10 parts of monosodium glutamate, 0.6 parts of malic acid, 50 parts of glucose, 1 part of potassium dihydrogen phosphate, 10 parts of yeast powder, 5 parts of corn steep liquor powder, and the balance is sterile water.

6. Use of the method for preparing high-EPA-producing Schizochytrium according to any one of claims 1 to 5 in producing high-EPA-producing Schizochytrium.